Recommended Watch: "Why Psychedelics Change Your Reality"
Amazing 6 minute video by John Hopkins Psychiatric Researcher, Dr. Matthew Johnson, explaining how psychedelics affect our biological and...
top of page
.png)
Is Ketamine for Me?
Determination of appropriateness for Ketamine treatment is of paramount concern for Attento.
All potential Ketamine treatment clients are required to complete an assessment/interview to determine “Medical Necessity and Appropriateness” for treatment. Following protocol guidelines, Attento KAP intervention is considered an “Adjunct Treatment” designed to support clients with the goal of long-term symptom management.
What is the Process?
At Attento, a counselor will complete a preliminary diagnostic evaluation in a first in preparation for client to our Partner Psychiatrist for medical appropriateness for treatment.
The Partner Psychiatrist will facilitate a formal medical review and determination of appropriateness/suitability for Ketamine Treatment. Upon determination, clients will be requested to review and sign an Informed Consent for treatment and receive additional information about treatment protocols as they prepare for their 1st KAP appointment
What Does the Research Say?
Growing research support in the medical community is finding Ketamine to be effective in helping clients with treatment resistant depression/anxiety and PTSD.
The most likely mechanism of action for Ketamine Treatment is activity on a receptor in the brain called NMDA receptors and its impact on a neurotransmitter called glutamate. This is a different pathway than most other psychiatric drugs including anti-anxiety, anti-depressant, anti-psychotic, and mood stabilizing medicines. In addition, Ketamine has additional effects in the brain including the facilitation of “neuroplasticity” (expanding neural pathways).
Ketamine was first tested in humans in 1964 and approved by the Food and Drug Administration (FDA) in 1970 as an anesthetic agent.
In 2019, Esketamine (nasal form of ketamine--brand name Spravato) was approved by the FDA for treatment resistant depression.
Ketamine has been used safely and repeatedly in research studies involving both healthy volunteers, individuals with psychiatric disorders as well as treatment for chronic pain conditions.
What is the Pricing?
Below is a summary of charges. For more details on pricing, please give us a call: 678.216.8167.
Recent Posts
bottom of page